About the Program

JOIN US for an opportunity to learn about the latest insights on the use and interpretation of blood-based biomarkers in clinical practice for Alzheimer’s disease.

Program Learning Objectives

• Explain which blood-based biomarkers are emerging as the most robust for diagnosing Alzheimer’s disease and how the main test platforms differ
• Identify circumstances in which blood-based biomarker testing could be beneficial to expedite the diagnosis of Alzheimer’s disease
• Discuss how to interpret blood-based biomarker results and determine next steps in the diagnosis of Alzheimer’s disease

Privacy Statement and Terms & Conditions